z-logo
Premium
Gypsogenin Derivatives: An Unexpected Class of Inhibitors of Cholinesterases
Author(s) -
Heller Lucie,
Schwarz Stefan,
Weber Björn A.,
Csuk René
Publication year - 2014
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.201400103
Subject(s) - butyrylcholinesterase , chemistry , acetylcholinesterase , stereochemistry , cholinesterase , aché , enzyme , galantamine , pharmacology , biochemistry , medicine , dementia , disease , pathology , donepezil
Gypsogenin ( 1 ) was obtained by acidic hydrolysis from its saponin. While the parent compound 1 acted as a selective inhibitor for butyrylcholinesterase (from equus) possessing a moderate mixed‐type inhibition of the enzyme, K i values as low as 2.67 ± 0.59 μM were determined for (3β,4α) 3‐ O ‐acetyl‐olean‐12‐ene‐23,28‐dinitrile ( 11 ) and acetylcholinesterase (AChE, from electric eel). Thus, 11 possesses one‐fifth of the inhibitory activity of the “gold standard” galantamine hydrobromide; this compound is one of the first pentacyclic triterpenoids described as a potent AChE‐selective inhibitor.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom